3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Gliosarcoma
1
Glioblastoma
1
Interventions
Temozolomide
8
sargramostim
2
pembrolizumab
2
Radiotherapy
2
Radiation
2
veliparib
1
selinexor
1
montanide ISA 51
1
lonafarnib
1
Vorinostat
1
Sucrose
1
Sonication
1
Sodium Chloride
1
Serotonin Antagonists
1
Salts
1
Photons
1
Perfusion Magnetic Resonance Imaging
1
Olanzapine
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Loperamide
1
Lomustine
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Drug Therapy
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Carboplatin
1
CLR1404
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Gliosarcoma
×
Sonication
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled